"Engineered Bacteria Target Cancer, Self-Eliminate, Leaving No Trace"

Engineered bacteria could revolutionize cancer treatment by targeting neoplasms, activating the immune system, and self-eliminating post-treatment, leaving no trace behind.

• Researchers are developing engineered bacteria that specifically target neoplasms, offering a potential breakthrough in localized cancer therapy.
• These bacteria are designed to interact with the immune system, enhancing its ability to identify and destroy cancer cells while minimizing damage to healthy tissue (biology).
• Ongoing clinical trials aim to assess the efficacy of these engineered bacteria in treating various cancers, including bladder cancer, with the hope of creating a new type of cancer vaccine.